Nykode Therapeutics’ Post

View organization page for Nykode Therapeutics, graphic

9,608 followers

Nykode's Chief Scientific Officer and Co-founder, Agnete Fredriksen, will be presenting at the 7th International Neoantigen Summit in Amsterdam from April 29th to May 1st. Agnete will share new preclinical data from our collaboration with Genentech, focusing on the differentiation of our proprietary vaccine technology.   Details for Nykode Therapeutics’ presentation are as follows:   🔹 Title: Optimizing RNA/DNA-Based Vaccine Design by Identifying Key Characteristics to Ensure Success of the Therapy 🕒 Time & Date: 10.00am CET, May 1, 2024   #NeoantigenSummit #Immunotherapy #VaccineTechnology #BiotechInnovation

To view or add a comment, sign in

Explore topics